Jennifer C. Robertson

Aberdeen, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity.

Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity.

Journal: Antimicrobial agents and chemotherapy

Published: May 25, 2021

Listening and spoken language outcomes after 5 years of cochlear implant use for children born preterm and at term.

Listening and spoken language outcomes after 5 years of cochlear implant use for children born preterm and at term.

Journal: Developmental medicine and child neurology

Published: April 26, 2021

Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial.

Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial.

Journal: PloS one

Published: July 10, 2020

NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile.

NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile.

Journal: Medical mycology

Published: December 19, 2019

Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate.

Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate.

Journal: Antimicrobial agents and chemotherapy

Published: October 05, 2018

Correction for Mercer et al., "NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus".

Correction for Mercer et al., "NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus".

Journal: Antimicrobial agents and chemotherapy

Published: February 25, 2018

Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial Infection.

Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial Infection.

Journal: Infection and immunity

Published: December 22, 2017

NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus.

NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus.

Journal: Antimicrobial agents and chemotherapy

Published: March 08, 2017

Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex.

Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex.

Journal: Antimicrobial agents and chemotherapy

Published: June 15, 2016

Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum.

Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum.

Journal: EBioMedicine

Published: July 07, 2015

Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis.

Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis.

Journal: Orphanet journal of rare diseases

Published: July 07, 2014

Novel fluorinated lipopeptides from Bacillus sp. CS93 via precursor-directed biosynthesis.

Novel fluorinated lipopeptides from Bacillus sp. CS93 via precursor-directed biosynthesis.

Journal: Amino acids

Published: April 03, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026